Clinical Trials Directory

Trials / Unknown

UnknownNCT04656860

Juice Plus Supplement Clinical Trial

Encapsulated Fruit and Vegetable Juice Concentrates, Cognition, and Inflammation - A Randomized Placebo-controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
University of Alabama, Tuscaloosa · Academic / Other
Sex
All
Age
55 Years – 90 Years
Healthy volunteers
Accepted

Summary

The study is designed to determine whether encapsulated fruit and vegetable juice concentrates can improve biological indicators of cognitive and multiple dimensions of memory and learning.

Detailed description

Preventive interventions that delay the onset of mild cognitive impairment and benign forgetfulness have the potential to delay or even prevent the onset of Alzheimer's disease. However, few studies have examined the feasibility of Encapsulated Fruit and Vegetable Juice Concentrates in robust clinical trials; this limitation prevents investigators from determining the real value of these supplements. Therefore, we propose to enroll 150 adults aged 55 and older to a 24-month randomized placebo-controlled trial. Participants enrolled in the experimental condition will be encouraged to consume 6 Encapsulated Fruit and Vegetable Juice Concentrates capsules per day and 33 grams of a soy-based beverage power per day, which included 5 grams of fiber. Participants enrolled in the controlled condition will receive six placebo capsules and encouraged to maintain an adequate diet. Primary outcomes will include objective measures of cognition, and a panel of inflammatory markers, peptides, enzymes, and other biological markers known to be associated with cognitive decline.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTJuice Plus+Participants will receive encapsulated fruit and vegetable juice concentrates or a placebo for a 24-month period

Timeline

Start date
2020-03-12
Primary completion
2022-03-12
Completion
2023-03-12
First posted
2020-12-07
Last updated
2021-04-08

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04656860. Inclusion in this directory is not an endorsement.